Comparison of Dysport Reconstitution at 1.5 mL and 2.5 mL for the Treatment of Moderate to Severe Glabellar Lines
Clinical trial NCT02718118 · COMPLETED
Trial details
- NCT number
- NCT02718118
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2016-10-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.